ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.

Hana Salimizand et al.PubMed ↗Publisher ↗

No numbers read from the abstract.